OC-13 A clinical-genetic risk score to predict cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts

A. Muñoz,C. Ay,E. Grilz,S. López,C. Font,V. Pachón,V. Castellón,V. Martínez-Marín,M. Salgado,E. Martínez,J. Calzas,A. Rupérez,E. Salas,I. Pabinger,J.M. Soria

Thrombosis Research（2021）

引用 4|浏览4

暂无评分

摘要

The ONCOTHROMB score for VTE risk in outpatients with cancer, which takes into account both clinical and genetic variables, better identifies patients who might benefit from primary thromboprophylaxis than does the Khorana score.

查看译文

关键词

clinical-genetic,cancer-associated

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要